ÂÜÀòÂÒÂ×

Nicklas Westerholm, born in 1976, took office in June 2017 and has previously worked in the AstraZeneca Group since 1995 in a number of global roles in various business areas, most recently as Vice President Project & Portfolio Management, Cardiovascular and Metabolic Diseases, Global Medicines Development Unit. Prior Nicklas has held positions such as Executive Officer & Vice President Japan Operations, Director Investor Relations, Head of Global API Supply and Head of Development Manufacture.

He has studied Analytical and Organic Chemistry at Stockholm University and Chemical Engineering at KTH, as well as studies at the University of Warwick, INSEAD, and Harvard Business School.